Oslo Cancer Cluster

We connect Norwegian health start-ups with global pharmaceutical companies. Please contact us if you are interested in our collaboration with AstraZeneca, recently featured in MedWatch (in Norwegian), where we are actively matching promising candidates to the company's innovation hub BioVentureHub.

Har startet jakten på norske helseselskaper til utveksling – Vi ser først og fremst etter selskaper innen bioteknologi, helseteknologi og bærekraftsteknologi, sier Astrazenecas G**o Bjøntegaard, som skal matche selskaper til selskapets innovasjonshub.

I Oslo Cancer Cluster Innovasjonspark ved Radiumhospitalet ligger Ullern videregående skole, en av Oslos meste ettertraktede og kjente skoler.
I 2019 fikk skolen et nytt studieprogram; Forskerlinjen.
Les hele saken her:

(+) På denne skolen løser de mord: – Jeg ante ikke hva jeg gikk til! I Oslo Cancer Cluster Innovasjonspark ved Radiumhospitalet ligger Ullern videregående skole, en av Oslos meste ettertraktede og kjente skoler.

“Hardly any modern antibiotics on the market work against MBL-producing bacteria and we now have a technology at hand that can become a game-changer.”

Bjørn Klem, CEO of AdjuTec Pharma AS, is ready to take the company's enzyme inhibitor into a First-In-Man clinical trial after the summer. In the first article of our new series The Start-up Spotlight, we interviewed Bjørn to learn more about the health challenge of antimicrobial resistance and the commercial opportunities of the new product his company is developing.

This series is produced in collaboration between the Norwegian health clusters Oslo Cancer Cluster, Norway Health Tech, Norwegian Smart Care Cluster, The Life Science Cluster and Biotech North, and funded by Viken fylkeskommune.

Fighting the pandemic of antimicrobial resistance This is the first article in the new series Start-up Spotlight, which features the most promising start-ups from the Norwegian health clusters. AdjuTec Pharma is preparing the company’s First-in-Human phase I clinical trial. The Norwegian start-up company AdjuTec Pharma has developed a new ant

Europe is gathering all its forces against cancer! This week, Oslo Cancer Cluster, Norges forskningsråd and Kreftforeningen travelled to Romania to meet with more than 50 partners from 28 countries in the ECHOS project.

"There is now an international community working together, building consortia and collaborating on ideas that we didn’t have before," commented Bettina Ryll, strategist for Nollvision Cancer | Vision Zero Cancer and one of the participants in the project.

ECHoS | Establishing of Cancer Mission Hubs: Networks and Synergies is a three-year project funded with 6 million euros under Horizon Europe and it is now in its second year.

Read more: https://www.cancermission.no/en/aktuelle-saker/2024/echos-brings-europe-together-against-cancer/

Thank you to Astrid Bjerke, Margarethe Biong and Ketil F. Widerberg for representing Norway at The Oncology Institute “Prof. Dr I. Chiricuta” in Cluj-Napoca in Romania this week.

Today, at the Oslo Science Park, H.R.H. Princess Astrid of Belgium was present in the audience when Charlotte Wu Homme, Head of Memberships and Events at Oslo Cancer Cluster, presented the cluster alongside leaders from the Norwegian Biotech and Life Sciences Ecosystem. The conference is one of the key events scheduled during the Belgian Economic Mission in Oslo from the 17th to the 19th of June.
More about the event here:
https://www.b2match.com/e/belgian-economic-mission-norway/components/40342/kqy8iG4dgC8E

The Belgian Economic Mission in Oslo is organised by the Foreign Trade Agency (BFTA), Wallonia Export & Investment Agency, Flanders Investment & Trade (FIT) and Hub.Brussels. The life sciences day's program is developed with the assistance and contributions of Innovasjon Norge, Legemiddelindustrien (LMI), The Life Science Cluster, Norway Health Tech, Oslo Cancer Cluster and Norwegian Smart Care Cluster.

A new project suggests to use artificial intelligence to improve cancer prevention and treatment in Norway.

The project will pioneer multi-agent, multimodal AI platforms designed for predicting future events based on sequences of past occurrences. It involves developing a foundation model for cancer medicine, leveraging extensive hospital records, national cancer registries, public databases, and scientific publications. This foundation model will be capable of considering the impact of medical actions on patients, the healthcare system, and society, even when data is incomplete or multimodal.

The proposal was recently submitted to Norges forskningsråd, by Oslo Cancer Cluster and a wide network of national and international partners.

Harnessing AI for cancer prevention and treatment A new project proposes to use AI to improve cancer care in Norway.

"Cancer affects us all. It does not discriminate by age, gender or nationality. This shared challenge calls for a united front, bringing together researchers, practicioners, industry leaders, and policymakers nationally and from around the world."

The words of State Secretary Ivar B. Prestbakmo, Norwegian Ministry of Education and Research, have seldom been more true. That is why it was an absolute joy to see so many from our community participate in the Summer gathering yesterday. We hope you gained new insights from the presentations and made some lasting connections during the networking session!

Thank you for joining us and we look forward to seeing you again as our activities pick up in August!

Summer vibes in our house The annual summer gathering brought together colleagues in the Norwegian oncology field.

- Forskerlinjen på Ullern er et spisset tilbud for motiverte forskerspirer fra hele Oslo. Der kan de fordype seg i realfag gjennom et unikt samarbeid med Oslo Cancer Cluster Innovasjonspark, sier Julie Remen Midtgarden, Byråd for utdanning (H), Oslo, i et debattinnlegg.
Les innlegget her:

Vi heier på forskerspirene Jeg er helt enig med Philip Flo, som i Aftenposten 30. mai skriver at forskerlinjen ved Ullern videregående skole bør bestå. Byrådet heier på ambisiøse elever, og vi er helt enige i at Norge må satse på kunnskap for å skape verdier for fremtiden – og løse dagens og morgendagens utfordrin...

We are pleased to welcome Geir Hetland, Chief Financial Officer of Thermo Fisher Scientific, to the board of Oslo Cancer Cluster. Hetland brings 30 years of experience from the life science industry and is dedicated to developing the cancer innovation and start-up community around Campus Radiumhospitalet. Thank you for coming onboard!

Geir Hetland joins the board of Oslo Cancer Cluster Geir Hetland, Chief Financial Officer of Thermo Fisher Scientific, is the latest addition to the board of Oslo Cancer Cluster. “I wish to contribute to the strategic direction and success of Oslo Cancer Cluster. The organisation has a great foundation to further develop to become one of the leadi

A warm and sunny welcome to our Summer Gathering & Introduction of Members on Thursday, June 13th 1 PM - 3 PM at Oslo Cancer Cluster Innovation Park.
See the event for more details and registration:

Summer Gathering & Introduction of Members Join this gathering and hear from the Ministry of Education and Research and meet OCC members. This June, Oslo Cancer Cluster (OCC) will host this annual event to gather OCC members and the oncology ecosystem for an opportunity to meet. State Secretary Ivar Bühring Prestbakmo, Ministry of Educat

Oslo Cancer Cluster wishes everyone a happy Pride month!
Love is love

We were pleased to receive visitors from the top-ranked US hospital the Mayo Clinic yesterday. They were curious to learn more about how cancer care, research and innovation is performed in Norway.

Thank you to Sigbjørn Smeland for introducing the Radium Hospital Campus with its brand new clinic building, belonging to Oslo University Hospital - a Comprehensive Cancer Centre.

Thank you to Else Marit Inderberg & Sébastien Wälchli for giving a tour of Oslo Cancer Cluster Incubator, where academics and private researchers work side-by-side to develop new and improved cancer therapies for patients.

Lastly, a big thank you to Marit Brandsæter Hagland (Norwegian Smart Care Cluster) and Ketil F. Widerberg (Oslo Cancer Cluster) for showing how the Norwegian health clusters work together to faster get new medicines and technologies to the patients.

How can small European countries make a big mark in cancer research? Yesterday, we received a visit from the Masaryk Memorial Cancer Institute (MMCI) of the Czech Republic. The visit included a tour of the Radium Hospital Campus, including the new Oslo University Hospital clinic building, the Institute of Cancer Research and the growing Oslo Cancer Cluster Innovation Park. Aside from making new connections, we exchanged experiences in launching precision cancer medicine initiatives, attracting cancer clinical trials and participating in large EU projects.

Thank you Prof. MD Marek Svoboda PhD, Director, doc. MD Tomáš Kazda, PhD. Head of Science, Research and Education and doc. MSc. Roman Hrstka, PhD, Head of Biobank for taking the time.

Thank you to Sigbjørn Smeland, Kjetil Tasken, Per Magnus Mæhle, Åslaug Helland, Mari Nygård and Ketil F. Widerberg for contributing with Norwegian perspectives on cancer innovation.

A warm and sunny welcome to our Summer Gathering & Introduction of Members on Thursday, June 13th 1 PM - 3 PM at Oslo Cancer Cluster Innovation Park.

See the event for more details and registration: https://oslocancercluster.no/events/event/summer-gathering-introduction-of-new-members-2024-open-house/

Listen to leading healthcare specialists discuss the future of and share their insights on how these advancements can be integrated into daily practice. Please join the webinar New possibilities for personalised breast cancer prevention on Thursday 30 May 15:00-16:15 via Zoom. This is a great opportunity to share ideas and ask real-time questions about personalised breast cancer prevention.

Webinar: New possibilities for personalised breast cancer prevention Welcome to a webinar on new possibilities for personalised breast cancer prevention We are happy to invite you to an online webinar discussing the latest possibilities for personalised breast cancer prevention. This webinar is intended for all healthcare professionals, including family physicians,

We were delighted to see a full house for our pre-Constitution Day breakfast today, celebrating May 17th.

Deputy Mayor Julianne Ofstad, along with our General Manager Ketil F. Widerberg, gave inspiring speeches. Talented young student soloist Bård Nystøy sang the national anthem accompanied by a piano, leading the crowd in a solemn sing-along.

Members, researchers, and colleagues engaged in conversations and mingled, getting a head start on the festivities of this week's significant day.

We are thrilled to relaunch Lunch & Learn at Oslo Cancer Cluster Incubator

We kicked of the Lunch & Learn series with the session «Toolbox for Intellectual Property Rights».

Birte Løken senior advisor at Patentstyret - Norwegian Industrial Property Office (NIPO), and senior advisors Oddgeir Hvidsten and Roar Jakobsen, Ph.D. from The Norwegian Directorate of Health (Helsedirektoratet) shared their expertise on the subject.

Did you miss our seminar about home tests and cancer screening? View the recording and read a summary of the highlights below.

This webinar also presented results from the AnteNOR project, a Norwegian-Estonian collaboration that has explored how to improve prevention and early detection of breast cancer in Norway for the last three years. Genetic tests, such as polygenic risk score (PRS), continue to be important tools in order to personalise cancer screening and make the necessary shift towards precision prevention.

We want to take this opportunity to thank all project partners and everyone that has contributed to the success of this project.

Project partners: Antegenes, Oslo University Hospital, University of Oslo, Vestre Viken HF, Oslo Cancer Cluster

Funded by: Norway Grants, EAS Enterprise Estonia

Home testing to improve cancer prevention Can home tests engage more people in cancer screening and save more lives?

Want to have a taste of Norwegian traditions and get to know Oslo Cancer Cluster a little better? Please join us along with colleagues from the oncology community for a delicious networking breakfast filled with Norwegian specialities. The festivities will begin next Monday (13 May) at 9:30 am on the fourth floor at Oslo Cancer Cluster. Feel free to bring along your co-workers to this special event!

https://oslocancercluster.no/events/event/pre-norwegian-constitution-day-networking-breakfast-open-house/

Did you miss the Investor Ready webinar on Friday?
Watch the stream to get tips and tricks on how to succeed with funding.

https://lnkd.in/dp-ive_h

The Section for Cellular Therapy’s Translational Research Unit in Norway has recently published two groundbreaking studies. The pre-clinical therapies were developed in the Oslo Cancer Cluster Incubator. Read more:

Cell therapy breakthroughs in cancer treatment The Translational Research Unit at the Section for Cellular Therapy based in Norway recently published two groundbreaking studies showcasing the potential of cell-based therapies in combating cancer. The research was developed in the labs of Oslo Cancer Cluster Incubator.

Interested in precision cancer prevention? Join our webinar (on-site or digital) tomorrow at 13:00-15:15 in Oslo Cancer Cluster Innovation Park as we present results from the AnteNOR project. Experts in the field of genetic tests and breast cancer will discuss how early detection can save and improve the lives of cancer patients across Europe.

Project partners: Antegenes, University of Oslo, Oslo University Hospital, Vestre Viken HF and Oslo Cancer Cluster

Results from the AnteNOR project: Norway’s way towards precision prevention Welcome to this hybrid seminar marking the end of the Antenor project.

Learn about the recent growth and success of Norwegian companies Lytix and Curida, members of Oslo Cancer Cluster.

Lytix and Curida: Growth and innovation Lytix Biopharma and Curida, both Norwegian-owned, have gained attention and acclaim for their innovative approaches and substantial contributions to the healthcare sector.

How can we make the roadmap for the health industry a reality in Norway? Today Ketil Widerberg, general manager of Oslo Cancer Cluster, left our input on the wall in Oslo Science Park. Follow our example and put up your own post-its too! The wall is open until 15:00 tomorrow: https://www.uio.no/forskning/tverrfak/veksthuset-for-verdiskaping/aktuelt/arrangement/2024/vi-varmer-opp-til-arendalsuka-innspillstorg-helsenaering.html

During Arendalsuka 2024, all the input will be delivered to the government and there will be a political debate (in Norwegian) about the health industry: https://program.arendalsuka.no/event/view/23167

Co-organisers: Veksthuset for verdiskaping – UiO Growth House, Universitetet i Oslo (UiO), Aleap, Health2B, Melanor, HelseOmsorg21-rådet, Oslo Science City, Norway Health Tech, Oslo Cancer Cluster, The Life Science Cluster, Inven2, Forskningsparken - Oslo Science Park

News from Oslo Cancer Cluster in April!

Subscribe to our newsletter Stay updated on innovations in cancer treatments. Get news from Oslo Cancer Cluster and our incubator once every month.

📣 De fire helseklyngene gikk denne uka sammen om et høringsinnspill til Stortinget, der de foreslår å stå sammen om en superklynge innen helse. Se hva de konkret foreslår.👇

🇬🇧 summary: The four health cluster leaders gave joint political input to the Norwegian parliament on 16 April 2024. They are suggesting to join forces for a supercluster in health.

Helseklyngene er The Life Science Cluster Norwegian Smart Care Cluster Norway Health Tech og Oslo Cancer Cluster.

Sammen om superklynge De fire helseklyngene gikk denne uka sammen om et høringsinnspill til Stortinget.